Diabetic nephropathy is associated with low-grade inflammation in Type 1 diabetic patients

Prediction of Creatinine Clearance from Serum Creatinine

Cockcroft, D. W., & Gault, H. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000180580 · Cited by 15,291 · see citing works

A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation

Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079 · see citing works

K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification

Levey, A. S., Coresh, J., Bolton, K., Culleton, B. F., Harvey, K. S., Ikizler, T. A., Johnson, C. A., Kausz, A., Kimmel, P. L., Kusek, J. W., et al. (2002) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 11,633 · see citing works

Elevated C-reactive protein levels in overweight and obese adults

Visser, M. (1999) · JAMA · doi:10.1001/jama.282.22.2131 · Cited by 2,494 · see citing works

Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-α,in Vivo1

Mohamed‐Ali, V., Goodrick, S., Rawesh, A., Katz, D. R., Miles, J. M., Yudkin, J. S., Klein, S., & Coppack, S. W. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4450 · Cited by 2,012 · see citing works

Omental and Subcutaneous Adipose Tissues of Obese Subjects Release Interleukin-6: Depot Difference and Regulation by Glucocorticoid 1

Fried, S. K., Bunkin, D. A., & Greenberg, A. S. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.3.4660 · Cited by 1,528 · see citing works

High-Sensitivity C-Reactive Protein: Potential Adjunct for Global Risk Assessment in the Primary Prevention of Cardiovascular Disease

Ridker, P. M. (2001) · Circulation · doi:10.1161/01.cir.103.13.1813 · Cited by 1,402 · see citing works

Interleukin-6 in Biology and Medicine

Akira, S., Taga, T., & Kishimoto, T. (1993) · Advances in immunology · doi:10.1016/s0065-2776(08)60532-5 · Cited by 1,384 · see citing works

NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X

Pickup, J. C., Mattock, M. B., Chusney, G. D., & Burt, D. J. (1997) · Diabetologia · doi:10.1007/s001250050822 · Cited by 1,241 · see citing works

Interleukin-6 induces cellular insulin resistance in hepatocytes.

Senn, J. J., Klover, P. J., Nowak, I. A., & Mooney, R. A. (2002) · Diabetes · doi:10.2337/diabetes.51.12.3391 · Cited by 883 · see citing works

Increased Urinary Albumin Excretion, Endothelial Dysfunction, and Chronic Low-Grade Inflammation in Type 2 Diabetes

Stehouwer, C. D. A., Gall, M.-A., Twisk, J. W. R., Knudsen, E., Emeis, J. J., & Parving, H.-H. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1157 · Cited by 652 · see citing works

Can clinical factors estimate insulin resistance in type 1 diabetes?

Williams, K. V., Erbey, J. R., Becker, D., Arslanian, S., & Orchard, T. J. (2000) · Diabetes · doi:10.2337/diabetes.49.4.626 · Cited by 640 · see citing works

The effect of proteinuria on relative mortality in Type 1 (insulin-dependent) diabetes mellitus

Borch‐Johnsen, K., Andersen, P. K., & Deckert, T. (1985) · Diabetologia · doi:10.1007/bf00281993 · Cited by 601 · see citing works

Muscle‐derived interleukin‐6: possible biological effects

Pedersen, B. K., Steensberg, A., & Schjerling, P. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.0329c.xd · Cited by 599 · see citing works

Transcription factor-κB (NF-κB) and renal disease

Guijarro, C., & Egido, J. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.059002415.x · Cited by 479 · see citing works

Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study

Festa, A., D'agostino, R., Howard, G., Mykkänen, L. M., Tracy, R. P., & Haffner, S. M. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00331.x · Cited by 368 · see citing works

Plasma concentration of C-reactive protein is increased in Type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation

Schalkwijk, C., Poland, D. C. W., van Dijk, W., Kok, A., EMEIS, J. J., Dräger, A. M., Doni, A., van Hinsbergh, V. W. M., & Stehouwer, C. D. A. (1999) · Diabetologia · doi:10.1007/s001250051162 · Cited by 309 · see citing works

Nephropathy in type 1 diabetes: A manifestation of insulin resistance and multiple genetic susceptibilities?

Orchard, T. J., Chang, Y.-F., Ferrell, R. E., Petro, N., & Ellis, D. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00507.x · Cited by 239 · see citing works

High-Sensitivity C-Reactive Protein: Potential Adjunct for Global Risk Assessment in the Primary Prevention of Cardiovascular Disease

Guijarro, C. (2001) · Circulation · doi:10.1161/circ.104.22.e127 · Cited by 138 · see citing works

Usefulness of a Highly Sensitive Urinary and Serum IL-6 Assay in Patients with Diabetic Nephropathy

Shikano, M., Sobajima, H., Yoshikawa, H., Toba, T., Kushimoto, H., Katsumata, H., Tomita, M., & Kawashima, S. (2000) · The Nephron journals/Nephron journals · doi:10.1159/000045634 · Cited by 121 · see citing works

Do ACE‐inhibitors suppress tumour necrosis factor‐α production in advanced chronic renal failure?

Stenvinkel, P., Andersson, P., Wang, T., Lindholm, B., Bergström, J. P., Palmblad, J. E. W., Heimbürger, O., & Cederholm, T. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00560.x · Cited by 117 · see citing works

Inflammation and advanced glycation end products in uremia: Simple coexistence, potentiation or causal relationship?

Schwedler, S. B., Schinzel, R., Vaith, P., & Wanner, C. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.59780032.x · Cited by 96 · see citing works

Elevated fibrinogen and the relation to acute phase response in diabetic nephropathy

Myrup, B., de Maat, M. P. M., Rossing, P. R., Gram, J., Kluft, C., & Jespersen, J. (1996) · Thrombosis Research · doi:10.1016/0049-3848(96)00021-7 · Cited by 64 · see citing works

Inflammation and advanced glycation end products in uremia: Simple coexistence, potentiation or causal relationship?

Schwedler, S. B., Schinzel, R., Vaith, P., & Wanner, C. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.07839.x · Cited by 35 · see citing works

Tumour necrosis factor-α, inflammatory biomarkers, and atherogenesis

Blake, G. (2002) · European Heart Journal · doi:10.1053/euhj.2001.2905 · Cited by 24 · see citing works

Elevated serum C-reactive protein associates with deterioration of renal function in transplant recipients

Teppo, A.-M., Törnroth, T., Honkanen, E. O., & Grönhagen-Riska, C. (2003) · Clinical Nephrology · doi:10.5414/cnp60248 · Cited by 16 · see citing works

Mechanisms of Diabetic Complications

Forbes, J. M., & Cooper, M. E. (2013) · Physiological Reviews · doi:10.1152/physrev.00045.2011 · Cited by 2,890 · see citing works

Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment

Samsu, N. (2021) · BioMed Research International · doi:10.1155/2021/1497449 · Cited by 1,001 · see citing works

Inflammation and the pathogenesis of diabetic nephropathy

Wada, J., & Makino, H. (2012) · Clinical Science · doi:10.1042/cs20120198 · Cited by 776 · see citing works

The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes

Groop, P.-H., Thomas, M. C., Moran, J. L., Wadèn, J., Thorn, L. M., Mäkinen, V.-P., Rosengård-Bärlund, M., Saraheimo, M., Hietala, K., Heikkilä, O., et al. (2009) · Diabetes · doi:10.2337/db08-1543 · Cited by 638 · see citing works

Chronic hyperglycemia mediated physiological alteration and metabolic distortion leads to organ dysfunction, infection, cancer progression and other pathophysiological consequences: An update on glucose toxicity

Giri, B., Dey, S., Das, T., Sarkar, M., Banerjee, J., & Dash, S. K. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.157 · Cited by 674 · see citing works

Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control

Lee, Y.-S., & Jun, H.-S. (2016) · Mediators of Inflammation · doi:10.1155/2016/3094642 · Cited by 503 · see citing works

Inflammation in Diabetic Nephropathy

Lim, A. K. H., & Tesch, G. H. (2012) · Mediators of Inflammation · doi:10.1155/2012/146154 · Cited by 439 · see citing works

Metabolic Syndrome in Type 1 Diabetes

Thorn, L. M., Forsblom, C. M., Fagerudd, J. A., Thomas, M. C., Pettersson-Fernholm, K., Saraheimo, M., Wadén, J., Rönnback, M., Rosengård‐Bärlund, M., af Björkesten, C.-G., et al. (2005) · Diabetes Care · doi:10.2337/diacare.28.8.2019 · Cited by 424 · see citing works

Bacterial Endotoxin Activity in Human Serum Is Associated With Dyslipidemia, Insulin Resistance, Obesity, and Chronic Inflammation

Lassenius, M., Pietiläinen, K., Kaartinen, K., Pussinen, P., Syrjänen, J., Forsblom, C., Pörsti, I., Rissanen, A., Kaprio, J., Mustonen, J., et al. (2011) · Diabetes Care · doi:10.2337/dc10-2197 · Cited by 404 · see citing works

Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes

Kodera, R., Shikata, K., Kataoka, H. U., Takatsuka, T., Miyamoto, S., Sasaki, M., Kajitani, N., Nishishita, S., Sarai, K., Hirota, D., et al. (2011) · Diabetologia · doi:10.1007/s00125-010-2028-x · Cited by 394 · see citing works

What Does Minor Elevation of C-Reactive Protein Signify?

Kushner, I., Rzewnicki, D., & Samols, D. R. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.06.057 · Cited by 372 · see citing works

What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium?

Satchell, S. C., & Tooke, J. E. (2008) · Diabetologia · doi:10.1007/s00125-008-0961-8 · Cited by 361 · see citing works

Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes.

Vestra, M. D., Mussap, M., Gallina, P., Bruseghin, M., Cernigoi, A., Saller, A., Plebani, M., & Fioretto, P. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004110961 · Cited by 316 · see citing works

Diabetic nephropathy in type 1 diabetes: a review of early natural history, pathogenesis, and diagnosis

Papadopoulou‐Marketou, N., Chrousos, G. P., & Kanaka‐Gantenbein, C. (2016) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2841 · Cited by 240 · see citing works

The Early Natural History of Nephropathy in Type 1 Diabetes

Mauer, M. S., Drummond, K., & for the International Diabetic Nephropathy Study Group (2002) · Diabetes · doi:10.2337/diabetes.51.5.1572 · Cited by 217 · see citing works

The Early Natural History of Nephropathy in Type 1 Diabetes

Steinke, J. M., Sinaiko, A. R., Kramer, M. S., Suissa, S., Chavers, B. M., Mauer, M., & for the International Diabetic Nephropathy Study Group (2005) · Diabetes · doi:10.2337/diabetes.54.7.2164 · Cited by 190 · see citing works

Evidence of Increased Inflammation and Microcirculatory Abnormalities in Patients With Type 1 Diabetes and Their Role in Microvascular Complications

Devaraj, S., Cheung, A., Jialal, I., Griffen, S. C., Nguyen, D. V., Glaser, N. S., & Aoki, T. T. (2007) · Diabetes · doi:10.2337/db07-0784 · Cited by 183 · see citing works

Targeting inflammation in diabetic nephropathy: a tale of hope

Moreno, J. A., Gómez‐Guerrero, C., Mas, S., Sanz, A. B., Lorenzo, Ó., Ruiz‐Ortega, M., Opazo-Ríos, L., Mezzano, S. A., & Egido, J. (2018) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2018.1538352 · Cited by 170 · see citing works

Epidemiology and Risk Factors for Diabetic Kidney Disease

Harjutsalo, V., & Groop, P. (2014) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2014.03.009 · Cited by 161 · see citing works

C3a and C5a receptor antagonists ameliorate endothelial-myofibroblast transition via the Wnt/β-catenin signaling pathway in diabetic kidney disease

Li, L., Chen, L., Zang, J., Tang, X., Liu, Y., Zhang, J., Bai, L., Yin, Q., Lu, Y., Cheng, J., et al. (2015) · Metabolism · doi:10.1016/j.metabol.2015.01.014 · Cited by 157 · see citing works

Involvement of inflammation-related miR-155 and miR-146a in diabetic nephropathy: implications for glomerular endothelial injury

Huang, Y., Liu, Y., Li, L., Su, B., Yang, L., Fan, W., Yin, Q., Chen, L., Cui, T., Zhang, J., et al. (2014) · BMC Nephrology · doi:10.1186/1471-2369-15-142 · Cited by 145 · see citing works

Berberine attenuates lipopolysaccharide-induced extracelluar matrix accumulation and inflammation in rat mesangial cells: Involvement of NF-κB signaling pathway

Jiang, Q. L., Liu, P., Wu, X., Liu, W., Shen, X., Lan, T., Xu, S., Peng, J., Xie, X. S., & Huang, H. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.07.023 · Cited by 144 · see citing works

Cytokine Biomarkers, Endothelial Inflammation, and Atherosclerosis in the Metabolic Syndrome: Emerging Concepts

Rizvi, A. A. (2009) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181a4158c · Cited by 137 · see citing works

Periodontitis and cardiometabolic disorders: The role of lipopolysaccharide and endotoxemia

Pussinen, P. J., Kopra, E., Pietiäinen, M., Lehto, M. J., Zarić, S., Paju, S., & Salminen, A. (2022) · Periodontology 2000 · doi:10.1111/prd.12433 · Cited by 138 · see citing works

Serum Adiponectin Is Increased in Type 1 Diabetic Patients With Nephropathy

Saraheimo, M., Forsblom, C. M., Fagerudd, J. A., Teppo, A., Pettersson-Fernholm, K., Frystyk, J., Flyvbjerg, A., Groop, P., & on behalf of the FinnDiane Study Group (2005) · Diabetes Care · doi:10.2337/diacare.28.6.1410 · Cited by 131 · see citing works

Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in Type 1 diabetic patients without clinically manifest macroangiopathy

Targher, G., Bertolini, L., Zoppini, G., Zenari, L., & Falezza, G. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01562.x · Cited by 128 · see citing works

Sitagliptin Prevents Inflammation and Apoptotic Cell Death in the Kidney of Type 2 Diabetic Animals

Marques, C., Mega, C., Gonçalves, A., Rodrigues-Santos, P., Teixeira-Lemos, E., Teixeira, F., Fontes-Ribeiro, C., Reis, F., & Fernandes, R. (2014) · Mediators of Inflammation · doi:10.1155/2014/538737 · Cited by 126 · see citing works

Redox regulation of MAPK phosphatase 1 controls monocyte migration and macrophage recruitment

Kim, H. S., Ullevig, S. L., Zamora, D. A., Lee, C. F., & Asmis, R. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1212596109 · Cited by 120 · see citing works

Mannose-Binding Lectin as a Predictor of Microalbuminuria in Type 1 Diabetes

Hovind, P. H., Hansen, T. K., Tarnow, L., Thiel, S., Steffensen, R., Flyvbjerg, A., & Parving, H. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1523 · Cited by 119 · see citing works

Novel Links between the Long Pentraxin 3, Endothelial Dysfunction, and Albuminuria in Early and Advanced Chronic Kidney Disease

Suliman, M. E., Yılmaz, M. İ., Carrero, J. J., Qureshi, A. R., Sağlam, M., İpçioğlu, O. M., Yenicesu, M., Tong, M., Heimbürger, O., Barany, P. F., et al. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03960907 · Cited by 117 · see citing works

Knockdown of Stat3 activity in vivo prevents diabetic glomerulopathy

Lu, T.-C., Wang, Z., Feng, X., Chuang, P. Y., Fang, W. Y., Shen, Y., Levy, D. E., Xiong, H., Chen, N., & He, C. (2009) · Kidney International · doi:10.1038/ki.2009.98 · Cited by 114 · see citing works

Serum Lipopolysaccharide Activity Is Associated With the Progression of Kidney Disease in Finnish Patients With Type 1 Diabetes

Nymark, M., Pussinen, P. J., Tuomainen, A. M., Forsblom, C. M., Groop, P., Lehto, M. J., & on behalf of the FinnDiane Study Group (2009) · Diabetes Care · doi:10.2337/dc09-0467 · Cited by 111 · see citing works

Upregulation of Angiotensin II Type 1 Receptor, Inflammatory Mediators, and Enzymes of Arachidonate Metabolism in Obese Zucker Rat Kidney

Xu, Z., Lanting, L. L., Vaziri, N. D., Li, Z., Sepassi, L., Rodríguez‐Iturbe, B., & Natarajan, R. D. (2005) · Circulation · doi:10.1161/01.cir.0000161831.07637.63 · Cited by 110 · see citing works

Risk Factors Related to Inflammation and Endothelial Dysfunction in the DCCT/EDIC Cohort and Their Relationship With Nephropathy and Macrovascular Complications

Lopes-Virella, M. F., Carter, R. E., Gilbert, G. E., Klein, R. L., Jaffa, M. A., Jenkins, A. J., Lyons, T. J., Garvey, W. T., Virella, G., & and the DCCT/EDIC Cohort Study Group (2008) · Diabetes Care · doi:10.2337/dc08-0659 · Cited by 102 · see citing works

Increased plasma adiponectin concentrations are associated with microangiopathy in type 1 diabetic subjects

Hadjadj, S., Aubert, R., Fumeron, F., Péan, F., Tichet, J., Roussel, R., Marre, M., & groups, S. A. D. S. (2005) · Diabetologia · doi:10.1007/s00125-005-1747-x · Cited by 102 · see citing works

The relation of C - reactive protein to chronic kidney disease in African Americans: the Jackson Heart Study

Fox, E. R., Benjamin, E. J., Sarpong, D. F., Nagarajarao, H. S., Taylor, J. K., Steffes, M. W., Salahudeen, A. K., Flessner, M. F., Akylbekova, E. L., Fox, C. S., et al. (2010) · BMC Nephrology · doi:10.1186/1471-2369-11-1 · Cited by 100 · see citing works

Association between mannose-binding lectin, high-sensitivity C-reactive protein and the progression of diabetic nephropathy in type 1 diabetes

on behalf of the FinnDiane Study Group, Hansen, T. K., Forsblom, C. M., Saraheimo, M., Thorn, L. M., Wadén, J., Høyem, P., Østergaard, J. A., Flyvbjerg, A., & Groop, P. (2010) · Diabetologia · doi:10.1007/s00125-010-1742-8 · Cited by 99 · see citing works

Cellular and humoral immune responses in the early stages of diabetic nephropathy in NOD mice

Xiao, X., Ma, B., Dong, B., Zhao, P., Tai, N., Chen, L., Wong, F. S., & Li, W. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2008.12.003 · Cited by 99 · see citing works

Inflammation and Progressive Nephropathy in Type 1 Diabetes in the Diabetes Control and Complications Trial

Lin, J., Glynn, R. J., Rifai, N., Manson, J. E., Ridker, P. M., Nathan, D. M., & Schaumberg, D. A. (2008) · Diabetes Care · doi:10.2337/dc08-0277 · Cited by 98 · see citing works

Microvascular complications in patients with cystic fibrosis-related diabetes (CFRD)

van den Berg, J. M. W., Morton, A. M., Kok, S. W., Pijl, H., Conway, S. P., & Heijerman, H. G. M. (2008) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2008.05.008 · Cited by 97 · see citing works

Increased levels of mannan-binding lectin in type 1 diabetic patients with incipient and overt nephropathy

Saraheimo, M., Forsblom, C. M., Hansen, T. K., Teppo, A.-M., Fagerudd, J. A., Pettersson-Fernholm, K., Thiel, S., Tarnow, L., Ebeling, P. R., Flyvbjerg, A., et al. (2004) · Diabetologia · doi:10.1007/s00125-004-1594-1 · Cited by 97 · see citing works

Aberrant cytokines/chemokines production correlate with proteinuria in patients with overt diabetic nephropathy

Wu, C., Chen, J.-S., Lu, K., Chen, C., Lin, S., Chu, P., Sytwu, H., & Lin, Y. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.01.036 · Cited by 92 · see citing works

Macrophage Scavenger Receptor-A–Deficient Mice Are Resistant Against Diabetic Nephropathy Through Amelioration of Microinflammation

Usui, H. K., Shikata, K., Sasaki, M., Okada, S., Matsuda, M., Shikata, Y., Ogawa, D., Kido, Y., Nagase, R., Yozai, K., et al. (2007) · Diabetes · doi:10.2337/db06-0359 · Cited by 91 · see citing works

Adiponectin Is Inversely Associated with Renal Function in Type 1 Diabetic Patients

Schalkwijk, C. G., Chaturvedi, N., Schram, M. T., Fuller, J., & Stehouwer, C. D. A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1117 · Cited by 91 · see citing works

Metabolic Phenotypes, Vascular Complications, and Premature Deaths in a Population of 4,197 Patients With Type 1 Diabetes

Mäkinen, V., Forsblom, C. M., Thorn, L. M., Wadén, J., Gordin, D., Heikkilä, O., Hietala, K., Kyllönen, L., Kytö, J., Rosengård‐Bärlund, M., et al. (2008) · Diabetes · doi:10.2337/db08-0332 · Cited by 92 · see citing works

IL-6 receptor blockade ameliorates diabetic nephropathy via inhibiting inflammasome in mice

Wu, R., Liu, X., Yin, J., Wu, H., Cai, X., Wang, N., Qian, Y., & Wang, F. (2018) · Metabolism · doi:10.1016/j.metabol.2018.01.002 · Cited by 90 · see citing works

The Gut-Kidney Axis: Putative Interconnections Between Gastrointestinal and Renal Disorders

Lehto, M. J., & Groop, P. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00553 · Cited by 86 · see citing works

Remnant cholesterol predicts progression of diabetic nephropathy and retinopathy in type 1 diabetes

Sigfrids, F. J., Dahlström, E. H., Forsblom, C. M., Sandholm, N., Harjutsalo, V., Taskinen, M., & Groop, P. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13298 · Cited by 85 · see citing works

Predictive impact of elevated serum level of IL-18 for early renal dysfunction in type 2 diabetes: an observational follow-up study

Araki, S., Haneda, M., Koya, D., Sugimoto, T., Isshiki, K., Chin‒Kanasaki, M., Uzu, T., & Kashiwagi, A. (2007) · Diabetologia · doi:10.1007/s00125-006-0586-8 · Cited by 83 · see citing works

Effects of berberine on matrix accumulation and NF-kappa B signal pathway in alloxan-induced diabetic mice with renal injury

Liu, W., Zhang, X., Liu, P., Shen, X., Lan, T., Li, W., Jiang, Q. L., Xie, X., & Huang, H. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.04.033 · Cited by 82 · see citing works

Sphingomyelin is associated with kidney disease in type 1 diabetes (The FinnDiane Study)

Mäkinen, V., Tynkkynen, T., Soininen, P., Forsblom, C. M., Peltola, T., Kangas, A. J., Groop, P., & Ala‐Korpela, M. (2011) · Metabolomics · doi:10.1007/s11306-011-0343-y · Cited by 82 · see citing works

Frequent and intensive physical activity reduces risk of cardiovascular events in type 1 diabetes

on behalf of the FinnDiane Study Group, Tikkanen-Dolenc, H., Wadén, J., Forsblom, C. M., Harjutsalo, V., Thorn, L. M., Saraheimo, M., Elonen, N., Rosengård‐Bärlund, M., Gordin, D., et al. (2016) · Diabetologia · doi:10.1007/s00125-016-4189-8 · Cited by 81 · see citing works

Baseline Markers of Inflammation Are Associated With Progression to Macroalbuminuria in Type 1 Diabetic Subjects

Lopes-Virella, M. F., Baker, N. L., Hunt, K. J., Cleary, P. A., Klein, R. L., & Virella, G. (2013) · Diabetes Care · doi:10.2337/dc12-2521 · Cited by 80 · see citing works

Targeting inflammation in diabetic kidney disease: early clinical trials

Pérez-Gómez, M. V., Sánchez-Niño, M. D., Sanz, A. B., Zheng-Lin, B., Martín-Cleary, C., Ruiz‐Ortega, M., Ortíz, A., & Fernández‐Fernández, B. (2016) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2016.1196184 · Cited by 79 · see citing works

Soluble receptor for AGE (RAGE) is a novel independent predictor of all-cause and cardiovascular mortality in type 1 diabetes

on behalf of the FinnDiane Study Group, Thomas, M. C., Söderlund, J., Lehto, M. J., Mäkinen, V., Moran, J. L., Cooper, M. E., Forsblom, C. M., & Groop, P. (2011) · Diabetologia · doi:10.1007/s00125-011-2186-5 · Cited by 80 · see citing works

DPP-4 inhibitor sitagliptin prevents inflammation and oxidative stress of heart and kidney in two kidney and one clip (2K1C) rats

Alam, M. A., Chowdhury, M. R. H., Jain, P., Sagor, M. A. T., & Reza, H. M. (2015) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-015-0095-3 · Cited by 77 · see citing works

Polydatin ameliorates experimental diabetes-induced fibronectin through inhibiting the activation of NF-κB signaling pathway in rat glomerular mesangial cells

Xie, X., Peng, J., Huang, K., Huang, J., Shen, X., Liu, P., & Huang, H. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.06.008 · Cited by 76 · see citing works

C-reactive protein promotes diabetic kidney disease in a mouse model of type 1 diabetes

Liu, F., Chen, H., Huang, X., Chung, A. C. K., Zhou, L., Fu, P., Szalai, A. J., & Lan, H. Y. (2011) · Diabetologia · doi:10.1007/s00125-011-2237-y · Cited by 74 · see citing works

Activation of Peroxisome Proliferator–Activated Receptor δ Inhibits Streptozotocin-Induced Diabetic Nephropathy Through Anti-Inflammatory Mechanisms in Mice

Matsushita, Y., Ogawa, D., Wada, J., Yamamoto, N., Shikata, K., Sato, C., Tachibana, H., Toyota, N., & Makino, H. (2011) · Diabetes · doi:10.2337/db10-1361 · Cited by 73 · see citing works

All-trans retinoic acid ameliorates inflammatory response mediated by TLR4/NF-κB during initiation of diabetic nephropathy

Sierra-Mondragón, E., Molina‐Jijón, E., Namorado-Tónix, C., Rodríguez‐Muñoz, R., Pedraza‐Chaverrí, J., & Reyes, J. L. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.06.002 · Cited by 72 · see citing works

Pattern recognition receptor‐mediated inflammation in diabetic vascular complications

Wang, X., Antony, V., Wang, Y., Wu, G., & Liang, G. (2020) · Medicinal Research Reviews · doi:10.1002/med.21711 · Cited by 73 · see citing works

HbA1c variability is associated with an increased risk of retinopathy requiring laser treatment in type 1 diabetes

on behalf of the FinnDiane Study Group, Hietala, K., Wadén, J., Forsblom, C. M., Harjutsalo, V., Kytö, J., Summanen, P. A., & Groop, P. (2013) · Diabetologia · doi:10.1007/s00125-012-2816-6 · Cited by 70 · see citing works

Markers of Inflammation and Oxidative Stress in the Development and Progression of Renal Disease in Diabetic Patients

Hojs, R., Ekart, R., Bevc, S., & Hojs, N. V. (2016) · The Nephron journals/Nephron journals · doi:10.1159/000447434 · Cited by 70 · see citing works

Serum adiponectin concentration is a positive predictor of all-cause and cardiovascular mortality in type 1 diabetes

Forsblom, C. M., Thomas, M. C., Moran, J. L., Saraheimo, M., Thorn, L. M., Wadén, J., Gordin, D., Frystyk, J., Flyvbjerg, A., Groop, P., et al. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02406.x · Cited by 69 · see citing works

Diagnosing diabetic nephropathy by 1H NMR metabonomics of serum

Mäkinen, V., Soininen, P., Forsblom, C., Parkkonen, M., Ingman, P., Kaski, K., Groop, P., & Ala-Korpela, M. (2007) · Magnetic Resonance Materials in Physics, Biology and Medicine · doi:10.1007/s10334-006-0054-y · Cited by 70 · see citing works

Protective effects of sarsasapogenin against early stage of diabetic nephropathy in rats

Liu, Y., Hao, Y., Chen, Y., Yin, S., Zhang, M., Kong, L., & Wang, T. (2018) · Phytotherapy Research · doi:10.1002/ptr.6088 · Cited by 66 · see citing works

Glucose-Dependent Insulinotropic Polypeptide Stimulates Osteopontin Expression in the Vasculature via Endothelin-1 and CREB

Berglund, L. M., Lyssenko, V., Ladenvall, C., Kotova, O., Edsfeldt, A., Pilgaard, K. A., Alkayyali, S., Brøns, C., Forsblom, C. M., Jonsson, A. E., et al. (2015) · Diabetes · doi:10.2337/db15-0122 · Cited by 65 · see citing works

Diabetes-Induced Activation of Canonical and Noncanonical Nuclear Factor-κB Pathways in Renal Cortex

Starkey, J. M., Haidacher, S. J., LeJeune, W. S., Zhang, X., Tieu, B. C., Choudhary, S., Brasier, A. R., Denner, L. A., & Tilton, R. G. (2006) · Diabetes · doi:10.2337/db05-1554 · Cited by 65 · see citing works

Use of Readily Accessible Inflammatory Markers to Predict Diabetic Kidney Disease

Winter, L., Wong, L., Jerums, G., Seah, J., Clarke, M. V., Tan, S. M., Coughlan, M. T., MacIsaac, R. J., & Ekinci, E. I. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00225 · Cited by 65 · see citing works

Leisure-time physical activity and development and progression of diabetic nephropathy in type 1 diabetes: the FinnDiane Study

on behalf of the FinnDiane Study Group, Wadén, J., Tikkanen-Dolenc, H., Forsblom, C. M., Harjutsalo, V., Thorn, L. M., Saraheimo, M., Tolonen, N., Rosengård‐Bärlund, M., Gordin, D., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3499-6 · Cited by 64 · see citing works

Intestinal alkaline phosphatase at the crossroad of intestinal health and disease – a putative role in type 1 diabetes

Lassenius, M. I., Fogarty, C. L., Blaut, M., Haimila, K., Riittinen, L., Paju, A., Kirveskari, J., Järvelä, J., Ahola, A. J., Gordin, D., et al. (2017) · Journal of Internal Medicine · doi:10.1111/joim.12607 · Cited by 63 · see citing works

Mangiferin Attenuates Renal Fibrosis Through Down-Regulation of Osteopontin in Diabetic Rats: EFFECTS OF MANGIFERIN ON RENAL FIBROSIS IN DIABETES

Zhu, X., Cheng, Y.-Q., Du, L., Li, Y., Zhang, F., Guo, H., Liu, Y.-W., & Yin, X.-X. (2015) · Phytotherapy Research · doi:10.1002/ptr.5254 · Cited by 66 · see citing works

Microvascular disease in children and adolescents with type 1 diabetes and obesity

Marcovecchio, M. L., & Chiarelli, F. (2010) · Pediatric Nephrology · doi:10.1007/s00467-010-1624-9 · Cited by 60 · see citing works

Complement deposition on renal histopathology of patients with diabetic nephropathy

Sun, Z., Li, X.-Q., Chang, D., Wang, S.-X., Liu, G., Chen, M., & Zhao, M. (2018) · Diabetes & Metabolism · doi:10.1016/j.diabet.2018.08.011 · Cited by 59 · see citing works

Tempol or candesartan prevents high-fat diet-induced hypertension and renal damage in spontaneously hypertensive rats

Chung, S., Park, C. W., Shin, S. J., Lim, J. H., Chung, H. W., Youn, D., Kim, H., Kim, B. S., Lee, J. H., Kim, G., et al. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp472 · Cited by 58 · see citing works

High levels of circulating interleukin-10 in diabetic nephropathy patients.

Myśliwska, J. M., Zorena, K., Semetkowska-Jurkiewicz, E., Rachoń, D., Suchanek, H., & Myśliwski, A. (2005) · PubMed · Cited by 58 · see citing works

Coagulation and inflammation in overt diabetic nephropathy: association with hyperhomocysteinemia

Aso, Y., Yoshida, N., Okumura, K.-I., Wakabayashi, S., Matsutomo, R., Takebayashi, K., & Inukai, T. (2004) · Clinica Chimica Acta · doi:10.1016/j.cccn.2004.05.006 · Cited by 56 · see citing works

Association between cardiac autonomic dysfunction and inflammation in type 1 diabetic patients: effect of beta-blockade

Lanza, G. A., Pitocco, D., Navarese, E. P., Sestito, A., Sgueglia, G. A., Manto, A., Infusino, F., Musella, T., Ghirlanda, G., & Crea, F. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm018 · Cited by 56 · see citing works

Bacterial infections in patients with type 1 diabetes: a 14-year follow-up study

Simonsen, J. R., Harjutsalo, V., Järvinen, A., Kirveskari, J., Forsblom, C. M., Groop, P., & Lehto, M. J. (2015) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2014-000067 · Cited by 55 · see citing works

Activation of Liver X Receptor Inhibits Osteopontin and Ameliorates Diabetic Nephropathy

Tachibana, H., Ogawa, D., Matsushita, Y., Bruemmer, D., Wada, J., Teshigawara, S., Eguchi, J., Horiguchi, C. S., Uchida, H. A., Shikata, K., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012010022 · Cited by 54 · see citing works

C-peptide reduces pro-inflammatory cytokine secretion in LPS-stimulated U937 monocytes in condition of hyperglycemia

Haidet, J., Cifarelli, V., Trucco, M., & Luppi, P. (2011) · Inflammation Research · doi:10.1007/s00011-011-0384-8 · Cited by 52 · see citing works

Epigenetics and Inflammation in Diabetic Nephropathy

Shao, B., Zhang, S., Li, H.-D., Meng, X., & Chen, H. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.649587 · Cited by 52 · see citing works

Does microalbuminuria predict illness severity in critically ill patients on the intensive care unit? A systematic review*

Gopal, S., Carr, B., & Nelson, P. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000217922.75068.ea · Cited by 52 · see citing works

Acute hyperglycaemia induces an inflammatory response in young patients with type 1 diabetes

Gordin, D., Forsblom, C. M., Rönnback, M., Parkkonen, M., Wadén, J., Hietala, K., & Groop, P. (2008) · Annals of Medicine · doi:10.1080/07853890802126547 · Cited by 52 · see citing works

Exosomes from high glucose-treated macrophages activate macrophages andinduce inflammatory responses via NF-κB signaling pathway in vitro and in vivo

Zhu, M. J., Sun, X., Qi, X., Xia, L., & Wu, Y. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106551 · Cited by 51 · see citing works

Study of the role of interleukin-6 and highly sensitive C-reactive protein in diabetic nephropathy in type 1 diabetic patients.

Shelbaya, S., Amer, H., Seddik, S., Aa, A., Im, S., Mohamed, T. Y. H., & El Mosely, M. (2012) · PubMed · Cited by 50 · see citing works

Does fenugreek ( Trigonella foenum-graecum ) seed improve inflammation, and oxidative stress in patients with type 2 diabetes mellitus? A parallel group randomized clinical trial

Tavakoly, R., Maracy, M. R., Karimifar, M., & Entezari, M. H. (2018) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2018.01.005 · Cited by 50 · see citing works

The effects of hesperidin and quercetin on serum tumor necrosis factor-alpha and interleukin-6 levels in streptozotocin-induced diabetes model

İskender, H., Dokumacıoğlu, E., Şen, T. M., İnce, İ., Dokumacıoğlu, A., Kanbay, Y., Erbaş, E., & Saral, S. (2018) · Pharmacognosy Magazine · doi:10.4103/pm.pm_41_17 · Cited by 50 · see citing works

The Serum IL-6 Profile and Treg/Th17 Peripheral Cell Populations in Patients with Type 1 Diabetes

Ryba-Stanisławowska, M. E., Skrzypkowska, M. W., Myśliwska, J. M., & Myśliwiec, M. (2013) · Mediators of Inflammation · doi:10.1155/2013/205284 · Cited by 49 · see citing works

Added Value of Soluble Tumor Necrosis Factor-α Receptor 1 as a Biomarker of ESRD Risk in Patients With Type 1 Diabetes

Forsblom, C. M., Moran, J. L., Harjutsalo, V., Loughman, T., Wadén, J., Tolonen, N., Thorn, L. M., Saraheimo, M., Gordin, D., Groop, P., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0225 · Cited by 49 · see citing works

Association Between IL-6 Concentration and Diabetes-Related Variables in DM1 Patients with and without Microvascular Complications

Wegner, M., Araszkiewicz, A., Pioruńska-Stolzmann, M., Wierusz‐Wysocka, B., & Zozulińska‐Ziółkiewicz, D. (2013) · Inflammation · doi:10.1007/s10753-013-9598-y · Cited by 48 · see citing works

C-peptide and long-term complications of diabetes

Luppi, P., Cifarelli, V., & Wahren, J. (2010) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2010.00729.x · Cited by 48 · see citing works

An IL-6 haplotype on human chromosome 7p21 confers risk for impaired renal function in type 2 diabetic patients

Ng, D., Nurbaya, S., Ye, S., & Królewski, A. S. (2008) · Kidney International · doi:10.1038/ki.2008.202 · Cited by 47 · see citing works

Are C-Reactive Protein Associated Genetic Variants Associated with Serum Levels and Retinal Markers of Microvascular Pathology in Asian Populations from Singapore?

Dorajoo, R., Li, R., Ikram, M. K., Liu, J., Froguel, P., Lee, J., Sim, X., Ong, R. T., Tay, W. T., Chen, P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067650 · Cited by 47 · see citing works

Biomarkers of Renal Disease and Progression in Patients with Diabetes

Hojs, R., Ekart, R., Bevc, S., & Hojs, N. V. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4051010 · Cited by 46 · see citing works

Silencing of USP22 suppresses high glucose-induced apoptosis, ROS production and inflammation in podocytes

Shi, J., Wang, Q.-J., Li, H., & Huang, Q. (2016) · Molecular BioSystems · doi:10.1039/c5mb00722d · Cited by 46 · see citing works

Lipotoxic and inflammatory phenotypes in rats with uncontrolled metabolic syndrome and nephropathy

Dominguez, J. H., Wu, P., Packer, C. S., Temm, C. J., & Kelly, K. J. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00021.2007 · Cited by 46 · see citing works

Trigonelline inhibits caspase 3 to protect β cells apoptosis in streptozotocin-induced type 1 diabetic mice

Liu, L., Du, X., Zhang, Z., & Zhou, J. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.08.025 · Cited by 45 · see citing works

Low risk of overt nephropathy after 24 yr of childhood-onset type 1 diabetes mellitus (T1DM) in Norway

Skrivarhaug, T., Bangstad, H., Stene, L. C., Sandvik, L., Hanssen, K. F., & Joner, G. (2006) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2006.00204.x · Cited by 44 · see citing works

Diabetes and Its Complications: Therapies Available, Anticipated and Aspired

Grover, A., Sharma, K., Gautam, S., Gautam, S., Gulati, M., & Singh, S. K. (2020) · Current Diabetes Reviews · doi:10.2174/1573399816666201103144231 · Cited by 43 · see citing works

The C-reactive Protein and Interleukin-6 in 65 Patients with Type 1 Diabetic Nephropathy

Yi-min, L. (2006) · Applied Journal of General Practice

Interleukin-6 and C-reactive protein in pathogenesis of diabetic nephropathy: new evidence linking inflammation, glycemic control, and microalbuminuria.

Choudhary, N., & Ahlawat, R. S. (2008) · Iranian Journal of Kidney Diseases · Cited by 66 · see citing works

Role of interleukin 6 and highly sensitive C-reactive protein in diabetic nephropathy

Abdelnabi, A.-S. M., & Sadek, A. M. E. M. (2018) · The Egyptian Journal of Internal Medicine · doi:10.4103/ejim.ejim_27_18 · Cited by 2 · see citing works

Study of the role of interleukin-6 and highly sensitive C-reactive protein in diabetic nephropathy in type 1 diabetic patients.

Shelbaya, S., Amer, H., Seddik, S., Aa, A., Im, S., Mohamed, T. Y. H., & El Mosely, M. (2012) · PubMed · Cited by 50 · see citing works

C-reactive protein is associated with high- normal urinary albumin excretion in normotensive and normoalbuminuric type 1 diabetic patients

Duvnjak, L. S., Bulum, J., Gracin, S., Car, N., & Metelko, Ž. (2005)